A publication titled "Navepegritide in children with achondroplasia" was published in Translational Pediatrics on July 31, 2026. The article is indexed under PubMed ID 42591755. This entry is noted alongside vosoritide, an approved compound, though the publication itself concerns navepegritide. No findings, outcomes, or results from the publication are described in the available event data. The listing confirms only that the article exists in the journal on the stated date. No details regarding study design, patient outcomes, or safety information are provided in this record. Readers seeking the full content of the publication should consult the original source directly for complete context. This brief reports only the existence and bibliographic details of the publication as supplied. For general background on vosoritide, its approved status, and related compound information, readers can consult the compound overview.</body_markdown>
<parameter name="sources">["https://pubmed.ncbi.nlm.nih.gov/42591755/"]